Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-13-003788
Filing Date
2013-04-01
Accepted
2013-04-01 16:01:47
Documents
12
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K ahro_10k-123112.htm 10-K 1379530
2 EXHIBIT 23.1 ex23-1.htm EX-23.1 5405
3 EXHIBIT 31.1 ex31-1.htm EX-31.1 15855
4 EXHIBIT 31.2 ex31-2.htm EX-31.2 15697
5 EXHIBIT 32.1 ex32-1.htm EX-32.1 6797
6 EXHIBIT 32.2 ex32-2.htm EX-32.2 6941
  Complete submission text file 0001437749-13-003788.txt   8464164

Data Files

Seq Description Document Type Size
7 ahro-20121231.xml EX-101.INS 1313986
8 ahro-20121231.xsd EX-101.SCH 74988
9 ahro-20121231_cal.xml EX-101.CAL 27376
10 ahro-20121231_def.xml EX-101.DEF 389788
11 ahro-20121231_lab.xml EX-101.LAB 527095
12 ahro-20121231_pre.xml EX-101.PRE 384964
Mailing Address 2301 DUPONT DRIVE, SUITE 525 IRVINE CA 92612
Business Address 2301 DUPONT DRIVE, SUITE 525 IRVINE CA 92612 (949) 525-5471
AtheroNova Inc. (Filer) CIK: 0001377053 (see all company filings)

EIN.: 201915083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52315 | Film No.: 13731086
SIC: 2834 Pharmaceutical Preparations